四川普锐特药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
16
NMPA:16
Drug Approvals
Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation
- Product Name
- 沙美特罗替卡松吸入粉雾剂
- Approval Number
- 国药准字H20253521
- Approval Date
- Mar 4, 2025
NMPA
Formoterol Fumarate Inhalation Solution
- Product Name
- 富马酸福莫特罗吸入溶液
- Approval Number
- 国药准字H20249155
- Approval Date
- Oct 22, 2024
NMPA
Dexmedetomidine Hydrochloride Nasal Spray
- Product Name
- 盐酸右美托咪定鼻喷雾剂
- Approval Number
- 国药准字H20240012
- Approval Date
- Apr 24, 2024
NMPA
Acetylcysteine Solution for Inhalation
- Product Name
- 吸入用乙酰半胱氨酸溶液
- Approval Number
- 国药准字H20234715
- Approval Date
- Dec 29, 2023
NMPA
Levosalbutamol Hydrochloride Nebuliser Solution
- Product Name
- 盐酸左沙丁胺醇雾化吸入溶液
- Approval Number
- 国药准字H20237015
- Approval Date
- Feb 9, 2023
NMPA
Levosalbutamol Hydrochloride Nebuliser Solution
- Product Name
- 盐酸左沙丁胺醇雾化吸入溶液
- Approval Number
- 国药准字H20237016
- Approval Date
- Feb 9, 2023
NMPA
Levosalbutamol Hydrochloride Nebuliser Solution
- Product Name
- 盐酸左沙丁胺醇雾化吸入溶液
- Approval Number
- 国药准字H20223091
- Approval Date
- Feb 23, 2022
NMPA
Terbutaline Sulfate Nebuliser Solution
- Product Name
- 硫酸特布他林雾化吸入用溶液
- Approval Number
- 国药准字H20223084
- Approval Date
- Feb 23, 2022
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found